Vetigenics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$6M
- Investors
-
6
Vetigenics General Information
Description
Operator of an animal health biotechnology company intended to improve the lives of companion animals through science and medicine. The company offers a proprietary, species-specific, phage display technology that creates safe, effective therapeutics to treat cancer, autoimmune, inflammatory, and infectious diseases, enabling veterinarians to improve the treatment options to offer pet parents for their beloved family members.
Contact Information
Website
www.vetigenics.comCorporate Office
- B. Labs Cira Centre, 2929 Arch Street
- Fourth Floor, Lab 436
- Philadelphia, PA 19104
- United States
Corporate Office
- B. Labs Cira Centre, 2929 Arch Street
- Fourth Floor, Lab 436
- Philadelphia, PA 19104
- United States
Vetigenics Timeline
Vetigenics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 03-Feb-2025 | $6M | Completed | Clinical Trials - Phase 1 | ||
| 5. Angel (individual) | 01-Sep-2023 | Completed | Clinical Trials - Phase 1 | |||
| 4. Angel (individual) | 01-Aug-2022 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Jan-2018 | $355K | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Vetigenics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Vetigenics Comparisons
Industry
Financing
Details
Vetigenics Competitors (3)
One of Vetigenics’s 3 competitors is Vetmab Bio, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vetmab Bio | Venture Capital-Backed | San Diego, CA | ||||
| PetMedix | Formerly VC-backed | Cambridge, United Kingdom | ||||
| MabGenesis | Venture Capital-Backed | Yokohama, Japan |
Vetigenics Patents
Vetigenics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3216131-A1 | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) | Pending | 21-Apr-2021 | ||
| EP-4326324-A1 | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) | Pending | 21-Apr-2021 | ||
| US-12110331-B2 | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) | Active | 21-Apr-2021 | ||
| US-20240109967-A1 | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) | Active | 21-Apr-2021 | ||
| US-20250171541-A1 | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) | Pending | 21-Apr-2021 | C07K16/2818 |
Vetigenics Signals
Vetigenics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Veterinary Angel Network for Entrepreneurs | Angel Group | Minority | ||
| Wilson Sonsini Goodrich & Rosati | VC-Backed Company | Minority | ||
| National Cancer Institute | Government | |||
| Astralabs | Accelerator/Incubator | Minority | ||
| Penn Center for Innovation | Accelerator/Incubator | Minority |
Vetigenics FAQs
-
When was Vetigenics founded?
Vetigenics was founded in 2017.
-
Where is Vetigenics headquartered?
Vetigenics is headquartered in Philadelphia, PA.
-
What is the size of Vetigenics?
Vetigenics has 10 total employees.
-
What industry is Vetigenics in?
Vetigenics’s primary industry is Other Commercial Services.
-
Is Vetigenics a private or public company?
Vetigenics is a Private company.
-
What is the current valuation of Vetigenics?
The current valuation of Vetigenics is .
-
What is Vetigenics’s current revenue?
The current revenue for Vetigenics is .
-
How much funding has Vetigenics raised over time?
Vetigenics has raised $7.25M.
-
Who are Vetigenics’s investors?
Veterinary Angel Network for Entrepreneurs, Wilson Sonsini Goodrich & Rosati, National Cancer Institute, Astralabs, and Penn Center for Innovation are 5 of 6 investors who have invested in Vetigenics.
-
Who are Vetigenics’s competitors?
Vetmab Bio, PetMedix, and MabGenesis are competitors of Vetigenics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process